Hervé P - Search Results

1

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.

Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P, Hervé P, Duroux P, Dinh-Xuan AT, Simonneau G. Raffy O, et al. Among authors: herve p. Circulation. 1996 Feb 1;93(3):484-8. doi: 10.1161/01.cir.93.3.484. Circulation. 1996. PMID: 8565165

2

Increased plasma serotonin in primary pulmonary hypertension.

Hervé P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. Hervé P, et al. Am J Med. 1995 Sep;99(3):249-54. doi: 10.1016/s0002-9343(99)80156-9. Am J Med. 1995. PMID: 7653484

3

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Herve P, Raffestin B, Simonneau G. Sitbon O, et al. Among authors: herve p. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):384-9. doi: 10.1164/ajrccm.151.2.7842196. Am J Respir Crit Care Med. 1995. PMID: 7842196 Clinical Trial.

4

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.

Petitpretz P, Brenot F, Azarian R, Parent F, Rain B, Herve P, Simonneau G. Petitpretz P, et al. Among authors: herve p. Circulation. 1994 Jun;89(6):2722-7. doi: 10.1161/01.cir.89.6.2722. Circulation. 1994. PMID: 8205687

5

Primary pulmonary hypertension and fenfluramine use.

Brenot F, Herve P, Petitpretz P, Parent F, Duroux P, Simonneau G. Brenot F, et al. Among authors: herve p. Br Heart J. 1993 Dec;70(6):537-41. doi: 10.1136/hrt.70.6.537. Br Heart J. 1993. PMID: 8280518 Free PMC article.

6

Pulmonary vascular disorders in portal hypertension.

Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Hervé P, et al. Eur Respir J. 1998 May;11(5):1153-66. doi: 10.1183/09031936.98.11051153. Eur Respir J. 1998. PMID: 9648972 Free article. Review.

7

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Sitbon O, Humbert M, Jagot JL, Taravella O, Fartoukh M, Parent F, Herve P, Simonneau G. Sitbon O, et al. Among authors: herve p. Eur Respir J. 1998 Aug;12(2):265-70. doi: 10.1183/09031936.98.12020265. Eur Respir J. 1998. PMID: 9727772 Free article.

8

Primary pulmonary hypertension associated with the use of fenfluramine derivatives.

Simonneau G, Fartoukh M, Sitbon O, Humbert M, Jagot JL, Hervé P. Simonneau G, et al. Among authors: herve p. Chest. 1998 Sep;114(3 Suppl):195S-199S. doi: 10.1378/chest.114.3_supplement.195s. Chest. 1998. PMID: 9741568 Review.

9

Severe pulmonary hypertension in histiocytosis X.

Fartoukh M, Humbert M, Capron F, Maître S, Parent F, Le Gall C, Sitbon O, Hervé P, Duroux P, Simonneau G. Fartoukh M, et al. Among authors: herve p. Am J Respir Crit Care Med. 2000 Jan;161(1):216-23. doi: 10.1164/ajrccm.161.1.9807024. Am J Respir Crit Care Med. 2000. PMID: 10619823

10

[Primary pulmonary artery hypertension (data of the literature and personal experience with 25 cases in 10 years)].

Brenot F, Hervé P, Rain B, Simonneau G. Brenot F, et al. Among authors: herve p. Rev Prat. 1991 Jun 11;41(17):1560-7. Rev Prat. 1991. PMID: 1853125 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters